This post is sponsored by the Center of Innovation for Nanobiotechnology.
Business executives from startups and growth-stage companies can network and share information at The North Carolina Nanotechnology Commercialization Conference’s Nanomedicine Commercialization Workshop on strategies for company building and moving to market.
The interactive workshop, titled “Actionable Strategies for Company Building and Moving to Market,” is scheduled for Tuesday, March 29, from 9 a.m. to 1 p.m. at The Barnhardt Center, UNC Charlotte, in Charlotte, North Carolina.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
This professional development workshop will clarify key business issues and provide an interactive forum to derive actionable growth strategies for advancing business development and strategic collaborations, assessing opportunities and navigating legal issues, among other topics.
Brief presentations by subject matter experts in business development, market strategy, legal issues and funding strategy will be followed by critical conversations — small breakout sessions led by experts. This derivation of the typical Q&A session allows participants to move from table to table depending on their interest in the topic being discussed and stimulate conversations about the questions with experts and participants alike. Thus, attendees will be key contributors in the dialogue at each table as well, by sharing their knowledge and experience.
The workshop will kick off with a business development panel. Business development is more important — and more competitive — than ever. During this workshop component, an expert will discuss:
• Areas of keen interest to pharma and biotech companies
• Deal structuring
• Opportunity assessment & valuation approaches as well as potential missteps
• How to pitch early-stage technology and platform technology for optimal outcomes
• Techniques for building & leveraging a business development network with limited resources
• Negotiation pointers for optimal outcomes
The marketing strategy session is designed to highlight the importance of including market strategy as a critical component of your overall commercialization plan early in the new product development process. In today’s highly competitive and quickly evolving markets, including input from key groups like customers, patients and payers can be the difference between success and failure. The content of this workshop will include why marketing strategy is critical during new product planning, case studies of nanomedicine companies that illustrate the importance of marketing strategy and frameworks that your company can use to inform product planning and development decisions.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
An important element for any commercialization strategy is navigating the legal and intellectual property landscape. For example, a cost-effective patent portfolio should be carefully developed to generate value. Competitive patents should be monitored. Non-patented technology also can be critical in intellectual property strategy, as well as intellectual property contract clauses. What should be unique considerations in managing a nanotech IP portfolio? How can value be generated and pitfalls avoided? What are the risks with government funding and university licensing? These and other legal and business topics will be explored in the legal session with an emphasis on recent developments and practical insights on what to do — and avoid.
In this economy and investment climate, only the best of the best will get the attention of investors. Whether you need to approach formal angel investor organizations, private investors or venture capital investors, you need to have a clear strategy and solid discipline to successfully raise any equity investment. The funding strategy session will give you a comprehensive primer on how to identify the right investors for your business and engage them.
The cost of the workshop is $35 for early-bird signup (ends Feb. 16) or $50 for regular signup. Box lunches will be provided. To register, click here or contact Ms. Clare Valcore by email ([email protected]) or phone: (919) 680-2070.
